Abiopharma

🔍 Morgan Kathleen A. (Executive)

Company: Iridium Communications Inc. (IRDM)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 32,648 shares of Common Stock at $50.34 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,415.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 544 shares of Common Stock at $50.85 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 124,871.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.84 to $50.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
• F2: This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.845 to $50.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.